Edition:
United States

Lennox International Inc (LII.N)

LII.N on New York Stock Exchange

205.74USD
16 Feb 2018
Change (% chg)

$-1.49 (-0.72%)
Prev Close
$207.23
Open
$206.88
Day's High
$211.87
Day's Low
$204.09
Volume
94,274
Avg. Vol
86,746
52-wk High
$222.31
52-wk Low
$159.83

Select another date:

Tue, Feb 6 2018

BRIEF-Lennox International Q4 EPS $1.02 From Continuing Operations

* LENNOX INTERNATIONAL REPORTS RECORD FOURTH QUARTER MARGIN AND PROFIT TO CAP RECORD YEAR AND RAISES 2018 EPS GUIDANCE FOR U.S. TAX LEGISLATION

BRIEF-Ovid Therapeutics Announces TAK-935/OV935 Granted Orphan Drug Designation By U.S. FDA For Treatment Of Lennox-Gastaut Syndrome

* OVID THERAPEUTICS ANNOUNCES TAK-935/OV935 GRANTED ORPHAN DRUG DESIGNATION BY U.S. FDA FOR TREATMENT OF LENNOX-GASTAUT SYNDROME

BRIEF-Lennox International Sees Fy18 Revenue Up 3 To 7 Percent

* REAFFIRMS FY 2017 ADJUSTED EARNINGS PER SHARE VIEW $7.75 TO $8.05 FROM CONTINUING OPERATIONS

BRIEF-Lennox International says Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated Nov 18, 2011

* Lennox International - ‍as of Nov 13, Lennox, Lpac, co entered into amendment to amended, restated receivables purchase agreement initially dated nov 18, 2011

Select another date: